NCT01010217 Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide Status COMPLETED Phase PHASE2
NCT01008462 Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT00995059 Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma Status WITHDRAWN Phase PHASE1/PHASE2
NCT00987103 Pharmacokinetic Study to Rectal and Sublingual Administration of Tacrolimus in Future Kidney Transplant Patients Status UNKNOWN Phase PHASE1
NCT00982072 Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease Status COMPLETED Phase PHASE4
NCT00950391 Enhancement of Functional Recovery After Peripheral Nerve Injury With Tacrolimus Status WITHDRAWN Phase PHASE1/PHASE2
NCT00946023 Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab Status TERMINATED Phase PHASE2
NCT00935298 Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal Transplantation Status COMPLETED Phase PHASE4
NCT00933231 Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts Status COMPLETED Phase PHASE3
NCT00931255 Tacrolimus to Sirolimus Conversion for Delayed Graft Function Status TERMINATED Phase PHASE4
NCT00928018 Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma Status COMPLETED Phase PHASE3
NCT00919503 Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders Status COMPLETED Phase PHASE2
NCT00914940 Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD Status TERMINATED Phase PHASE2
NCT00896012 Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal Status COMPLETED Phase PHASE4
NCT00895583 Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients Status COMPLETED Phase PHASE4
NCT00890500 Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies. Status COMPLETED Phase PHASE1
NCT00885820 Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection Status COMPLETED Phase PHASE4